Statement from FDA for Devices and Radiological Health, on FDA’s updates to Medical Device Safety A
date:Nov 21, 2018
rket data and real-world evidence, is central to empowering the FDA to identify, communicate and act on new or increased medical device safety concerns. Such data serves as the foundation of our commitment to improving our nations post-market medical device surveillance. Its one of the core pillars of our safety plan.

Investing in New Tools, Policies and Resources to Enhance Post-Market Safety

The goal that were establishing today ensuring that the FDA is consistently first among the worlds r

07/13 10:53